To the extent that an objective of the longstanding U.S. economic embargo of Cuba was the stifling of creative enterprise, the architects of the embargo would have done betterto remember that ideas, especially in science and technology, laugh at borderguards. Despite an absolute ban on U.S. economic activity, an array of restrictions proscribing the ways that U.S. trading partners can transact business, and a host of minor interferences, such as threatening suppliers of essential spare parts, Cuba'sbiotechnology is now a fully developed, integrated set of industries that last year generated close to S200 million from the worldwide sale of its products. With the recent introduction of a pichia-produced, recombinant hepatitis B vaccine. Cuba now exports more than a dozen biotechnology-derived Pharmaceuticals.
展开▼
